BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 13, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

GLYC-101: Interim Phase II data

Interim data from the first 26 patients in an ongoing, double-blind, U.S. Phase II trial in patients undergoing carbon dioxide laser skin resurfacing on the lower eyelid area...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >